EPO and chronic kidney disease: At the end of the 1970s, before the introduction of erythropoietin therapy, several studies demonstrated a correlation between serum ferritin and bone marrow iron content in both hemodialysis patients and non-dialyzed chronic kidney disease (CKD) patients, and concluded that ferritin was a reliable indicator of iron storage levels [25–28].